Apoio à pesquisa:
(ESRF) European Synchrotron Radiation Facility

País

France

orgunit.page.state

Abrangência

Categoria

URL permanente para citação desta referência

https://hml-repositorio.butantan.gov.br/handle/butantan/5441

Identificador ROR

Filtros

Configurações

Apoio à pesquisa: search.filters.isFundingAgencyOfPublication.04178486-b02c-4eb4-b518-476cd12ecec7

Resultados da Pesquisa

Agora exibindo 1 - 2 de 2
  • Article Open access
    3D visualisation of hepatitis B vaccine in the oral delivery vehicle SBA-15 [2019]
    Rasmussen, Martin K.
    Kardjilov, Nikolay
    Oliveira, Cristiano L. P.
    Watts, Benjamin
    Villanova, Julie
    Fantini, Marcia C. A.
    Bordallo, Heloisa N.
    Sci Rep  2019 Apr;9:6106
    Publicação incluída no repositório: 2020-07-09
    Developing a technology that enables oral vaccines to work efficiently remains a considerable effort since a number of difficulties must be addressed. The key objective being to ensure the safe passage through the harsh conditions within the gastrointestinal tract, promoting delivery that induces enhanced immune response. In the particular case of hepatitis B, the oral formulation in the nanostructured silica SBA-15 is a viable approach. As a result of its porous structure, low toxicity and structural stability, SBA-15 is capable to protect and release the hepatitis B surface antigen (HBsAg), used in the vaccination scheme, at the desired destination. Furthermore, when compared to the currently used injection based delivery method, better or similar antibody response has been observed. However, information about the organisation of the antigen protein remains unknown. For instance, HBsAg is too large to enter the 10?nm ordered mesopores of SBA-15 and has a tendency to agglomerate when protected by the delivery system. Here we report on the pH dependence of HBsAg aggregation in saline solution investigated using small angle X-rays scattering that resulted in an optimisation of the encapsulation conditions. Additionally, X-ray microscopy combined with neutron and X-ray tomography provided full 3D information of the HBsAg clustering (i.e. agglomeration) inside the SBA-15 macropores. This method enables the visualisation of the organisation of the antigen in the interior of the delivery system, where agglomerated HBsAg coexists with its immunological effective uniformly distributed counterpart. This new approach, to be taken into account while preparing the formulation, can greatly help in the understanding of clinical studies and advance new formulations.
  • Article Restricted access
    Assessing the efficiency of SBA-15 as a nanocarrier for diphtheria anatoxin [2021]
    Rasmussen, Martin Kjærulf
    Bordallo, Heloisa N.
    Microp and Mesop Mater  2021 Jan;312:110763
    Publicação incluída no repositório: 2021-01-04
    SBA-15 ordered mesoporous silica can be considered a promising inorganic nanocarrier with emerging potential as an oral vaccine adjuvant. In this study, we investigated its application in the encapsulation of the diphtheria anatoxin (dANA). We observed a considerable preservation of dANA secondary and tertiary structures, even after the drying process by means of Circular Dichroism (CD) and fluorescence spectroscopies. Antigen loading was assessed at a number of different ratios of adjuvant-to-antigen using a combination of nitrogen adsorption porosimetry and Small Angle X-ray Scattering (SAXS). Our data showed that the mass ratio of 1:10 (dANA:SBA-15) is recommended for total encapsulation of dANA in the mesopores, considering that at this relative mass concentration antigen clustering was avoided, which is deleterious effect for immunization purposes. dANA release in mimetic intestine fluid, at a pH equal to 6.8, was followed by in-situ SAXS measurements and shown to be slow, being more pronounced after 6 h and continuous up to 35 h. Finally, the immunogenic complex was tested in isogenic Balb C mice by oral and subcutaneous immunization routes, including a comparison with the only permitted adjuvant for human use, aluminum hydroxide. A higher antibody titer was obtained by subcutaneous and oral administration routes using SBA-15 as the vehicle of dANA, compared with the conventional aluminum hydroxide, demonstrating the viability to use this ordered mesoporous silica in the formulation of oral vaccines, as already proved for the Virus Like Particles (VLP) Hepatitis B (HBsAg) case.